MG
BNTX icon

Marex Group’s BioNTech BNTX Stock Holding History

Marex Group’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$513K Buy
5,511
+2,698
+96% +$254K ﹤0.01% 692
2026
Q1 		$250K Sell
2,813
-8,898
-76% -$914K ﹤0.01% 834
2025
Q4 		$1.11M Buy
11,711
+7,500
+178% +$756K 0.01% 391
2025
Q3 		$415K Buy
+4,211
New +$450K ﹤0.01% 550
2025
Q2 		– Sell
-4,212
Closed -$384K – 676
2025
Q1 		$384K Sell
4,212
-42
-1% -$4.7K 0.01% 398
2024
Q4 		$485K Sell
4,254
-922
-18% -$105K 0.01% 349
2024
Q3 		$615K Sell
5,176
-10,420
-67% -$958K 0.01% 275
2024
Q2 		$1.25M Buy
15,596
+4,598
+42% +$420K 0.03% 198
2024
Q1 		$1.01M Buy
10,998
+4,175
+61% +$400K 0.03% 176
2023
Q4 		$720K Buy
6,823
+317
+5% +$31.9K 0.03% 255
2023
Q3 		$707K Sell
6,506
-685
-10% -$75.8K 0.1% 92
2023
Q2 		$776K Sell
7,191
-961
-12% -$108K 0.14% 106
2023
Q1 		$1.02M Buy
8,152
+2,673
+49% +$367K 0.13% 105
2022
Q4 		$823K Buy
+5,479
New +$843K 0.12% 127

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

Marex Group's BNTX Position: Q2 2026 in Review

Marex Group increased its BioNTech (BNTX) stake by 96% in Q2 2026, buying an estimated $254K and bringing the position to 5,511 shares worth $513K. The position accounts for ﹤0.01% of the portfolio, ranked #692.

Marex Group first reported a position in BNTX in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.25M in Q2 2024. 283 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Marex Group held 5,511 shares of BioNTech worth $513K as of Q2 2026.
  • Marex Group bought 2,698 BioNTech shares in Q2 2026, an estimated $254K.
  • BioNTech made up ﹤0.01% of Marex Group's portfolio in Q2 2026, its #692 holding.
  • Marex Group first reported a position in BioNTech in Q4 2022 and has held it in 14 quarters since.
  • Marex Group's BioNTech position peaked at $1.25M in Q2 2024.
  • 283 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.